Company / Debt per Share
Axsome Therapeutics, Inc. Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$2.42
FY2025
5-year range
$1.30 / $4.09
FY2021-FY2025
Trend
-36.6%
vs FY2024
Sector context
#40 of 82
Health Care
What the data says
At $2.42, Axsome Therapeutics, Inc.'s debt per share ranks #43 of 82 in the Health Care sector. Improved from $4.09 to $2.42 over the past 2 years.
Based on SEC 10-K filings.
2.42 in FY2025 with a 5-year CAGR of +13.2%.
Improved from $4.09 to $2.42 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- +13.2%
- 10-Year CAGR
- -
Sector benchmark
#43 of 82 in Health CareTop 51% of 82This company $2.42 Sector average $151.59
▼
-98.4% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 36.6% year-over-year.
- Ranks #40 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2023.
- Lowest debt per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.42 | -36.6% |
| FY2024 | $3.82 | -6.8% |
| FY2023 | $4.09 | +64.2% |
| FY2022 | $2.49 | +91.0% |
| FY2021 | $1.30 | +0.5% |
| FY2020 | $1.30 | +154.9% |
| FY2019 | $0.51 | +278.4% |
| FY2018 | $0.13 | -54.0% |
| FY2017 | $0.29 | -40.8% |
| FY2016 | $0.49 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026